Evidence map›Paper›PMID 41706886›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Enhanced screening via a pure DNA-encoded peptide library enabled by an Fmoc modification.

Qiujin He, Yanhui Wang, Xiyuan Tang, Jianwei Zhang, Yuyu Xing, Zhaoyun Zong, Mohamed A Elhamouly, Kaixian Chen, Shiyu Chen

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qiujin He *Biotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Yanhui Wang *Biotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0002-9759-7856
Xiyuan TangSchool of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Jianwei ZhangBiotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Yuyu XingBiotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Zhaoyun ZongBiotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Mohamed A ElhamoulyBiotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0001-6061-9102
Kaixian ChenDrug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Shiyu ChenBiotech Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.ORCID 0000-0001-6578-561X

Funding

MOST | National Natural Science Foundation of China (NSFC) 22477128
6 · The paper itself

Abstract

Peptide-based molecules have widespread therapeutic applications due to their potent binding affinity and relative metabolic safety. Peptide therapeutics are developed using library screening that samples a diverse chemical space within primary sequences and secondary structural conformations. DNA-encoded peptide libraries (PDELs) are ideal for the development of peptide-based therapeutics as novel building blocks, and diverse chemical modifications are easily incorporated. However, current PDEL construction is limited by precipitation-based purification, which constrains libraries to three or four building blocks in length due to decreasing quality with each synthetic step. Herein, we developed a solid-phase capture-based purification method to generate longer PDELs with increased purity. We modified the conventional Fmoc protecting group with an azido handle to introduce click chemistry for selective immobilization during purification. Using this method, we achieved >95% purity in the synthesis of a five-round PDEL that showed great efficiency in identifying high nanomolar binders against transferrin receptor protein 1. This work delivers a scalable and robust platform for generating high-quality, noncanonical peptide libraries, which marks a major breakthrough in peptide-based drug discovery.

Indexed as

DNAFluorenesPeptide LibraryPeptidesClick ChemistryDNAFluorenesPeptide LibraryPeptidesamino protectioncell penetrating peptideDNA-encoded libraryDNA-encoded peptide librarypeptide screening

Identifiers

PMID41706886
PMCPMC12933050

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.